AG2R La Mondiale Gestion d'Actifs’s AbbVie ABBV Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.4M	Buy	70,975 +940	+1%	+$209K	0.7%	19
2025 Q4	$16M	Buy	70,035 +4,114	+6%	+$937K	0.71%	20
2025 Q3	$12.2M	Hold	65,921	–	–	0.63%	24
2025 Q2	$12.2M	Buy	65,921 +764	+1%	+$142K	0.63%	24
2025 Q1	$12.1M	Buy	+65,157	New	+$12.7M	0.66%	23

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's ABBV Position: Q1 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its AbbVie (ABBV) stake by 1.3% in Q1 2026, buying an estimated $209K and bringing the position to 70,975 shares worth $15.4M. The position accounts for 0.7% of the portfolio, ranked #19.

AG2R La Mondiale Gestion d'Actifs first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $16M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

AG2R La Mondiale Gestion d'Actifs held 70,975 shares of AbbVie worth $15.4M as of Q1 2026.
AG2R La Mondiale Gestion d'Actifs bought 940 AbbVie shares in Q1 2026, an estimated $209K.
AbbVie made up 0.7% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q1 2026, its #19 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
AG2R La Mondiale Gestion d'Actifs's AbbVie position peaked at $16M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q1 2026, filed 12 May 2026.